SMMT — SUMMIT THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying SMMT?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
No tracked investor changed their SMMT position last quarter. Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).
- +4 tracked investors reported holding SMMT at their latest filing
- +Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.
About SUMMIT THERAPEUTICS INC (SMMT)
SUMMIT THERAPEUTICS INC (SMMT) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $56M. All data sourced from SEC 13F filings.
Based on recent institutional activity in SMMT
No recent activity recorded.
How many top investors track SMMT
A small number of top investors own this.
SMMT Ownership Composition
How SUMMIT THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant99.6%
- Macro0.4%
Tracked investors currently reporting SMMT
- Ken GriffinJun 30, 2026Citadel AdvisorsShares2.9MValue$41.9M% Portfolio0.00%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares3.7MValue$53.9M% Portfolio0.06%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares2.3MValue$34.2M% Portfolio0.01%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares37.8KValue$550.7K% Portfolio0.00%
Recent activity
- No recent activity.
Frequently asked questions
- How many institutional investors hold SMMT?
- 4 tracked institutional investors disclosed a position in SMMT (SUMMIT THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of SMMT?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in SMMT, valued at $56M.
- Did institutional ownership of SMMT increase or decrease?
- Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited SMMT.
- Where does this SMMT ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.